BioHarvest Sciences shares rise 10.47% intraday as CEO highlights VINIA growth, CDMO milestones, and $19.9M equity offering ahead of Craig-Hallum conference.

BioHarvest Sciences Inc. surged 10.47% in intraday trading following its announcement of participating in the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025. CEO Ilan Sobel highlighted growth in the VINIA consumer line and CDMO platform, including new product launches and a breakthrough in plant-based exosome production. The company also disclosed a $19.9M equity offering and progress toward near-term adjusted EBITDA breakeven, signaling financial strength and operational momentum. These developments, emphasizing expanded market reach, technological innovation, and capital raising, likely fueled investor optimism. The conference engagement with institutional investors further underscored strategic positioning for sustainable growth, aligning with the stock’s upward movement.